generic medicine

  1. S

    Biocon Gains USFDA Approval for Dapagliflozin Tablets

    New Delhi, April 8 Biocon Ltd announced on Wednesday that its subsidiary, Biocon Pharma Ltd, has received approval from the US health regulator for its genetically engineered version of dapagliflozin tablets, indicated for reducing blood sugar levels in adults with type 2 diabetes mellitus.The...
  2. S

    Mankind Pharma Gains Access to Rivotril Market

    New Delhi, March 18 Mankind Pharma announced on Wednesday that it has acquired the Rivotril brand from Roche for the Indian market, gaining exclusive rights to manufacture, market, and distribute the product across the country.Rivotril is the original brand of clonazepam and is widely...
  3. D

    Supreme Court Defers Restraint on Zydus's Cancer Drug Biosimilar

    New Delhi, February 11 The Supreme Court on Wednesday refused to restrain Zydus Lifesciences from selling its affordable, generic biosimilar of Nivolumab, a life-saving cancer drug registered by Bristol Myers Squibb (BMS).A bench of Chief Justice Surya Kant and Justice Joymalya Bagchi was...
Back
Top